{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:53:18Z","timestamp":1780725198080,"version":"3.54.1"},"reference-count":47,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NARSAD Young Investigator Award","award":["27364"],"award-info":[{"award-number":["27364"]}]},{"name":"Pennsylvania Department of Health using Tobacco CURE Funds","award":["27364"],"award-info":[{"award-number":["27364"]}]},{"name":"PA Options for Wellness","award":["27364"],"award-info":[{"award-number":["27364"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>(1) Background: Recently, a number of side chain length variants for tetrahydrocannabinol and cannabidiol have been identified in cannabis; however, the precursor to these molecules would be based upon cannabigerol (CBG). Because CBG, and its side chain variants, are rapidly converted to other cannabinoids in the plant, there are typically only small amounts in plant extracts, thus prohibiting investigations related to CBG and CBG variant therapeutic effects. (2) Methods: To overcome this, we developed an efficient synthesis of corresponding resorcinol fragments using the Wittig reaction which, under acid catalyzed coupling with geraniol, produced the desired side chain variants of CBG. These compounds were then tested in an animal model of chemotherapeutic-induced neuropathic pain and to reduce colorectal cancer cell viability. (3) Results: We found that all side-chain variants were similarly capable of reducing neuropathic pain in mice at a dose of 10 mg\/kg. However, the molecules with shorter side chains (i.e., CBGV and CBGB) were better at reducing colorectal cancer cell viability. (4) Conclusions: The novel synthesis method developed here will be of utility for studying other side chain derivatives of minor cannabinoids such as cannabichromene, cannabinol, and cannabielsoin.<\/jats:p>","DOI":"10.3390\/biom12121869","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T02:22:41Z","timestamp":1670984561000},"page":"1869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-9852","authenticated-orcid":false,"given":"Wesley M.","family":"Raup-Konsavage","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana E.","family":"Sepulveda","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"},{"name":"Department of Anesthesiology & Perioperative Medicine, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantu","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent E.","family":"Vrana","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Graziane","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"},{"name":"Department of Anesthesiology & Perioperative Medicine, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9367-8600","authenticated-orcid":false,"given":"Dhimant","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"ref_1","unstructured":"Society, A.C. (2022, October 03). Key Statistics for Colorectal Cancer. Available online: https:\/\/www.cancer.org\/cancer\/colon-rectal-cancer\/about\/keystatistics.html#:~:text=Excluding%20skin%20cancers%2C%20colorectal%20cancer,new%20cases%20of%20rectal%20cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e10608","DOI":"10.1016\/j.heliyon.2022.e10608","article-title":"Cisplatin for cancer therapy and overcoming chemoresistance","volume":"8","author":"Ranasinghe","year":"2022","journal-title":"Heliyon"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Buyana, B., Naki, T., Alven, S., and Aderibigbe, B.A. (2022). Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911261"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.21873\/anticanres.15971","article-title":"Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy","volume":"42","author":"Avallone","year":"2022","journal-title":"Anticancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aet208","article-title":"Neuropathic pain in cancer","volume":"111","author":"Fallon","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00558","DOI":"10.1002\/brb3.558","article-title":"Chemotherapy-induced neuropathies-a growing problem for patients and health care providers","volume":"7","author":"Banach","year":"2017","journal-title":"Brain Behav."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/can.2018.0065","article-title":"Synthetic Cannabinoid Activity Against Colorectal Cancer Cells","volume":"3","author":"Johnson","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000510256","article-title":"Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in Vitro","volume":"3","author":"Greenland","year":"2020","journal-title":"Med. Cannabis Cannabinoids"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1158\/0008-5472.CAN-05-4566","article-title":"Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation","volume":"66","author":"Caffarel","year":"2006","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","article-title":"The combination of cannabidiol and \u03949-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model","volume":"13","author":"Scott","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2019.01.011","article-title":"Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells","volume":"447","author":"Jeong","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"684115","DOI":"10.3389\/fmolb.2021.684115","article-title":"Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain","volume":"8","author":"Crawford","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/can.2021.0108","article-title":"Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice","volume":"7","author":"Sepulveda","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ejp.2016","article-title":"Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy","volume":"26","author":"Sepulveda","year":"2022","journal-title":"Eur. J. Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1111\/bph.13887","article-title":"Single and combined effects of \u03949-tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain","volume":"174","author":"King","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1213\/ANE.0b013e3182283486","article-title":"Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice","volume":"113","author":"Ward","year":"2011","journal-title":"Anesth. Analg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/can.2021.0100","article-title":"Inhibition of Sphingosine Kinase Activity Enhances Immunogenic Cell Surface Exposure of Calreticulin Induced by the Synthetic Cannabinoid 5-epi-CP-55,940","volume":"7","author":"Hengst","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000521683","article-title":"Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals","volume":"107","author":"Legare","year":"2022","journal-title":"Pharmacology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20335","DOI":"10.1038\/s41598-019-56785-1","article-title":"A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than \u03949-tetrahydrocannabinol: \u03949-Tetrahydrocannabiphorol","volume":"9","author":"Citti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"22019","DOI":"10.1038\/s41598-020-79042-2","article-title":"Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: Cannabidihexol","volume":"10","author":"Linciano","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acs.jnatprod.9b00876","article-title":"Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: \u03949-Tetrahydrocannabutol, the Butyl Homologue of \u03949-Tetrahydrocannabinol","volume":"83","author":"Linciano","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.120.000340","article-title":"The Pharmacological Case for Cannabigerol","volume":"376","author":"Nachnani","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acsmedchemlett.5b00170","article-title":"Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators","volume":"6","author":"Nomura","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_27","unstructured":"Kavarana, M., and Peet, R. (2016). Bioenzymatic Synthesis of THCV, CBV, and CBN and Their Use as Therapeutic Agents. (US-2017283837-A1), Patent."},{"key":"ref_28","unstructured":"Filer, C. (2021). Cannabinoid Derivatives."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ejoc.202001633","article-title":"A Novel and Practical Continuous Flow Chemical Synthesis of Cannabidiol (CBD) and its CBDV and CBDB Analogues","volume":"2021","author":"Sampaolesi","year":"2021","journal-title":"Eur. J. Org. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1021\/jm070121a","article-title":"C1\u2019-cycloalkyl side chain pharmacophore in tetrahydrocannabinols","volume":"50","author":"Papahatjis","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1021\/jf302872a","article-title":"Synthesis and inhibitory activities against colon cancer cell growth and proteasome of alkylresorcinols","volume":"60","author":"Zhu","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/ejoc.201900059","article-title":"A Revised Modular Approach to (\u2013)-trans-\u03948-THC and Derivatives Through Late-Stage Suzuki\u2013Miyaura Cross-Coupling Reactions","volume":"2019","author":"Bloemendal","year":"2019","journal-title":"Eur. J. Org. Chem."},{"key":"ref_33","unstructured":"Abdur-Rashid, K., Jia, W., and Abdur-rashid, K. (2020). Catalytic Cannabigerol Processes and Precursors. (WO2021195751A1), Patent."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1744-8069-10-56","article-title":"Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: Use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status","volume":"10","author":"Guindon","year":"2014","journal-title":"Mol. Pain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/jo9610624","article-title":"Simple Synthesis of 5-Substituted Resorcinols:\u2009 A Revisited Family of Interesting Bioactive Molecules","volume":"62","author":"Alonso","year":"1997","journal-title":"J. Org. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"152891","DOI":"10.1016\/j.tetlet.2021.152891","article-title":"Using (+)-carvone to access novel derivatives of (+)-ent-cannabidiol: The first asymmetric syntheses of (+)-ent-CBDP and (+)-ent-CBDV","volume":"67","author":"Golliher","year":"2021","journal-title":"Tetrahedron Lett."},{"key":"ref_37","unstructured":"Chemical, C. (2022, October 02). CBGV Cannabigerol. Available online: https:\/\/www.caymanchem.com\/product\/9002437\/cannabigerovarin."},{"key":"ref_38","unstructured":"(2022, October 02). Available online: https:\/\/www.caymanchem.com\/product\/15293\/cannabigerol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","article-title":"Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid","volume":"35","author":"Borrelli","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","article-title":"Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: Pro-apoptotic effects and underlying mechanisms","volume":"168","author":"Ligresti","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"22494","DOI":"10.1038\/s41598-021-01975-z","article-title":"Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin","volume":"11","author":"Russo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Salbini, M., Quarta, A., Russo, F., Giudetti, A.M., Citti, C., Cannazza, G., Gigli, G., Vergara, D., and Gaballo, A. (2021). Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells. Molecules, 26.","DOI":"10.3390\/molecules26185576"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/bjc.1985.205","article-title":"Adrenergic factors regulating cell division in the colonic crypt epithelium during carcinogenesis and in colonic adenoma and adenocarcinoma","volume":"52","author":"Kennedy","year":"1985","journal-title":"Br. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cbi.2010.06.001","article-title":"Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone","volume":"188","author":"Ban","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"G266","DOI":"10.1152\/ajpgi.00486.2001","article-title":"Controversy: PPARgamma as a target for treatment of colorectal cancer","volume":"283","author":"Gupta","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0016-5085(98)70072-1","article-title":"Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells","volume":"115","author":"Brockman","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br. J. Pharmacol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/12\/1869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:40:31Z","timestamp":1760146831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/12\/1869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["biom12121869"],"URL":"https:\/\/doi.org\/10.3390\/biom12121869","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]}}}